Novartis Canada is pleased to announce that Fabhalta® (iptacopan capsules) is now available across Canada for adult patients ...

Carla Nester, MD, MSA, FASN, is coinvestigator for the ongoing APPEAR-C3G trial (NCT04817618), data from which were used to ...

Birmingham Vasculitis Activity Scores (BVAS) were used to identify disease manifestations. Key efficacy outcomes included remission at week 26, sustained remission at week 52, relapse rates, the ...

Microbix Showcasing novel QAPs, Customer Presenting Pilot EQA Program ResultsMISSISSAUGA, Ontario, April 09, 2025 (GLOBE ...

With pristine national parks, glorious coastline and rich indigenous culture and history, what’s not to love about Central ...

Planning a trip to Honduras in 2025? Discover how to make your journey safe and enjoyable with practical tips and insights ...

Novartis has chalked up another clinical trial win for its targeted factor B inhibitor iptacopan as it strives to position the drug as a patient-friendly, oral alternative to big-selling ...

A Copan man is facing misdemeanor charges of larceny after allegedly stealing a PlayStation 5 and multiple video games from ...

The FDA has promised a fast review for Bayer's cancer drug, copanlisib, for a hard-to-treat lymphoma. The drug has been given a priority review, which means the FDA gives a six-month review ...

Former Copan head football coach Marshall Foreman has resigned his position with the Hornets to take an assistant coaching ...

The firm recently announced agreements with Labcorp and Quest Diagnostics to provide its devices for self-collection of vaginal swab specimens.